Iván Olmos Cansino
Iván Olmos Cansino is the head of Birmex, the Mexican biological and reagent laboratory, who has recently been in the news for addressing irregularities in the consolidated purchase of medications for 2025-2026. His leadership comes at a challenging time, as the Mexican government seeks to rectify issues that have led to significant shortages of essential medicines, which have drawn scrutiny and criticism from various sectors.
Global Media Ratings
Countries Mentioned
| Country | Mentions | Sentiment | Dominance | + Persistence | x Population | = Reach | x GDP (millions) | = Power |
|---|---|---|---|---|---|---|---|---|
| Mexico | 1 | 4.00 | 0.12% | +0% | 128,932,753 | 155,528 | $1,200,000 | 1,448$ |
| Totals | 1 | 128,932,753 | 155,528 | $1,200,000 | 1,448$ |
Interactive World Map
Each country's color is based on "Mentions" from the table above.
Recent Mentions
Mexico:
Iván Olmos Cansino was replaced as the director of Birmex due to irregularities.
4
Mexico:
Iván Olmos Cansino is the director of BIRMEX who is involved in a corruption scandal.
3
Mexico:
Iván Olmos Cansino is the head of Birmex, responsible for addressing issues in the consolidated medication purchase.
5